ClinicalTrials.gg
Combination product

Tilatamig samrotecan clinical trials

Also written AZD9592.

studies test it
3
open now
0
in phase 3
0
first study started
2021

How each study uses tilatamig samrotecan has had a first review. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

AZD9592
3

In one entry with another drug

Given together, or one or the other

AZD9592 + Rilvegostomig
2
AZD9592 + Volrustomig
2
AZD9592 + Sabestomig
2
AZD9592 + Pembrolizumab
2

Studies by the year they started

3 studies that test it; most in 2021 (1)

Studies that test tilatamig samrotecan, by start year
YearStudies
20211
20221
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 0

Presage Biosciences (2) · AstraZeneca (1)

Often tested with

Tested in the same studies.

Rilvegostomig (2) · Volrustomig (2) · Sabestomig (2) · Pembrolizumab (1)

Studies

Open first, then newest update. How each study uses tilatamig samrotecan has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Tested with established drugs · 1 — they are given beside it
Tested in a combination · 2 — another drug in the study is under test too

Codes

What other systems call tilatamig samrotecan · ClinicalTrials.gg INT016117

  • UNII (FDA) BL5C53FB6HTILATAMIG SAMROTECANOne source FDA
  • NCI Thesaurus C192091Tilatamig SamrotecanOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion